A clinical trial to see the effect of Tranexamic Acid in reducing blood loss during cesarean sectio

Phase 4

Completed

• Conditions: Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

• Registration Number: CTRI/2021/02/031579
• Lead Sponsor: AIIMS Raipur

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Completion: 2022-03-26
• Last Update Posted: 17 October 2022

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 72

Inclusion Criteria

1.Subjects with singleton pregnancy (parity not more than 3)

2.Age � 18 and < 35 years.

3.� 37 weeks and < 42 weeks of gestation

4.Alive fetus.

5.Hb � 9 g % in recent 3rd trimester report.

6.Subjects receiving spinal anaesthesia for Cesarean Section

Exclusion Criteria

1.History of venous (deep vein thrombosis and/or pulmonary embolism) or arterial (angina pectoris, myocardial infarction, stroke) thrombosis

2.Subjects with medical disorders like chronic hypertension, renal disease, heart disease, liver disease complicating pregnancy

3.Known case of coagulation disorders

4.Pregnancy related complication like severe preeclampsia, multiple pregnancy, polyhydramnios, and macrosomia, with abnormal placentation, previous two or more caesarean sections

5.Intrauterine death

6.Woman on anticoagulant therapy during the week before delivery

7.Sickle cell disease

8.History of seizures

9.Allergy to TXA.

Study & Design

• Study Type: Interventional
• Study Design: Not specified